CAN
TMBR

Cetera Advisor Networks’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Cetera Advisor Networks’s Portfolio TMBR Stock Details TMBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,043
Closed -$207K – 1945
2021
Q1 		$207K Buy
+2,043
New +$176K ﹤0.01% 1359

Other funds holding TMBR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cetera Advisor Networks's TMBR Position: Q2 2021 in Review

Cetera Advisor Networks sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q2 2021, closing a stake of 2,043 shares — an estimated $207K sold.

Cetera Advisor Networks first reported a position in TMBR in Q1 2021 and held it in 1 quarter. The position peaked at $207K in Q1 2021. 15 funds tracked by Wall St. Rank hold TMBR as of Q2 2021.

  • Cetera Advisor Networks reported no remaining Timber Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Cetera Advisor Networks sold 2,043 Timber Pharmaceuticals, Inc. shares in Q2 2021, an estimated $207K.
  • Cetera Advisor Networks first reported a position in Timber Pharmaceuticals, Inc. in Q1 2021 and held it in 1 quarter.
  • Cetera Advisor Networks's Timber Pharmaceuticals, Inc. position peaked at $207K in Q1 2021.
  • 15 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q2 2021.

Based on Cetera Advisor Networks's 13F filing for Q2 2021, filed 13 Aug 2021.